TreeWAS – Variant ID: rs13501

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J45.9 Asthma, unspecified	0.000	0.000	1.000
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
E03.9 Hypothyroidism, unspecified	0.000	0.016	0.984
I25 Chronic ischaemic heart disease	0.984	0.016	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.982	0.018	0.000
E03 Other hypothyroidism	0.000	0.020	0.980
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.020	0.980
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.020	0.980
E00-E07 Disorders of thyroid gland	0.000	0.025	0.975
I20-I25 Ischaemic heart diseases	0.966	0.034	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.040	0.960
M07.3 Other psoriatic arthropathies	0.958	0.042	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.956	0.044	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.955	0.045	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.951	0.049	0.000
I25.1 Atherosclerotic heart disease	0.919	0.081	0.000
I20 Angina pectoris	0.909	0.091	0.000
I25.2 Old myocardial infarction	0.901	0.099	0.000
I20.0 Unstable angina	0.897	0.103	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.115	0.885
M07.36 Other psoriatic arthropathies (Lower leg)	0.877	0.123	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.874	0.126	0.000
I24 Other acute ischaemic heart diseases	0.858	0.142	0.000
L40.4 Guttate psoriasis	0.857	0.143	0.000
J45 Asthma	0.000	0.151	0.849
I22 Subsequent myocardial infarction	0.842	0.158	0.000
E07 Other disorders of thyroid	0.000	0.172	0.828
L40.0 Psoriasis vulgaris	0.825	0.175	0.000
L40.1 Generalised pustular psoriasis	0.819	0.181	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.816	0.184	0.000
J45.0 Predominantly allergic asthma	0.000	0.191	0.809
I21 Acute myocardial infarction	0.807	0.193	0.000
I23 Certain current complications following acute myocardial infarction	0.801	0.199	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.765	0.235	0.000
K90 Intestinal malabsorption	0.000	0.245	0.755
I24.9 Acute ischaemic heart disease, unspecified	0.753	0.247	0.000
I24.8 Other forms of acute ischaemic heart disease	0.753	0.247	0.000
L40.3 Pustulosis palmaris et plantaris	0.728	0.272	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.725	0.275	0.000
L40.8 Other psoriasis	0.723	0.277	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
I25.0 Atherosclerotic cardiovascular disease, so described	0.713	0.287	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.709	0.291	0.000
I25.6 Silent myocardial ischaemia	0.705	0.294	0.000
I25.3 Aneurysm of heart	0.705	0.295	0.000
E03.5 Myxoedema coma	0.000	0.297	0.703
E03.4 Atrophy of thyroid (acquired)	0.000	0.297	0.703
E03.3 Postinfectious hypothyroidism	0.000	0.297	0.703
E05.5 Thyroid crisis or storm	0.000	0.298	0.702
E05.4 Thyrotoxicosis factitia	0.000	0.298	0.702
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.298	0.702
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.298	0.702
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.301	0.699
E00 Congenital iodine-deficiency syndrome	0.000	0.301	0.699
E03.1 Congenital hypothyroidism without goitre	0.000	0.304	0.696
I21.9 Acute myocardial infarction, unspecified	0.688	0.312	0.000
M07.38 Other psoriatic arthropathies (Other)	0.687	0.313	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.687	0.313	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.687	0.313	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.687	0.313	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.317	0.683
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.682	0.318	0.000
E05.8 Other thyrotoxicosis	0.000	0.323	0.677
J45.1 Nonallergic asthma	0.000	0.335	0.665
E07.8 Other specified disorders of thyroid	0.000	0.341	0.659
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.652	0.348	0.000
I20.1 Angina pectoris with documented spasm	0.651	0.349	0.000
I25.5 Ischaemic cardiomyopathy	0.650	0.350	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.354	0.645
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.356	0.644
L40-L45 Papulosquamous disorders	0.639	0.361	0.000
K90.8 Other intestinal malabsorption	0.000	0.365	0.635
I20.9 Angina pectoris, unspecified	0.619	0.381	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.617	0.383	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.610	0.390	0.000
J45.8 Mixed asthma	0.000	0.391	0.609
C82.0 Small cleaved cell, follicular	0.604	0.396	0.000
I22.8 Subsequent myocardial infarction of other sites	0.602	0.397	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.398	0.602
I24.1 Dressler's syndrome	0.599	0.401	0.000
E03.8 Other specified hypothyroidism	0.000	0.402	0.598
E07.1 Dyshormogenetic goitre	0.000	0.406	0.594
E07.0 Hypersecretion of calcitonin	0.000	0.406	0.594
I21.X Presumed acute myicardial infaction (unconfirmed)	0.578	0.421	0.000
I23.8 Other current complications following acute myocardial infarction	0.577	0.423	0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.574	0.425	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.574	0.425	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.574	0.425	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.574	0.425	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.574	0.425	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.574	0.425	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.426	0.574
I21.3 Acute transmural myocardial infarction of unspecified site	0.572	0.428	0.000
L43 Lichen planus	0.571	0.429	0.000
K90.3 Pancreatic steatorrhoea	0.000	0.458	0.541
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.458	0.541
K90.1 Tropical sprue	0.000	0.458	0.541
C82.1 Mixed small cleaved and large cell, follicular	0.528	0.472	0.000
L43.9 Lichen planus, unspecified	0.525	0.475	0.000
I25.4 Coronary artery aneurysm	0.523	0.477	0.000
I22.0 Subsequent myocardial infarction of anterior wall	0.505	0.495	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.499	0.501
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.499	0.501
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.499	0.501
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.499	0.501
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.499	0.501
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.499	0.501
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.499	0.501
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.499	0.501
C82.3 Follicular lymphoma grade IIIa	0.475	0.524	0.000
C44 Other malignant neoplasms of skin	0.471	0.529	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.470	0.530	0.000
C44.2 Skin of ear and external auricular canal	0.469	0.531	0.000
C82.2 Large cell, follicular	0.464	0.536	0.000
C44.3 Skin of other and unspecified parts of face	0.460	0.540	0.000
L44 Other papulosquamous disorders	0.458	0.542	0.000
L41 Parapsoriasis	0.458	0.542	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.458	0.542	0.000
C82.6 Cutaneous follicle centre lymphoma	0.442	0.558	0.000
C82.5 Diffuse follicle centre lymphoma	0.442	0.558	0.000
C44.7 Skin of lower limb, including hip	0.442	0.558	0.000
M07 Psoriatic and enteropathic arthropathies	0.436	0.564	0.000
L42 Pityriasis rosea	0.431	0.568	0.000
C82.4 Follicular lymphoma grade IIIb	0.421	0.579	0.000
C44.0 Skin of lip	0.410	0.590	0.000
L43.3 Subacute (active) lichen planus	0.409	0.590	0.000
L43.2 Lichenoid drug reaction	0.409	0.590	0.000
L43.1 Bullous lichen planus	0.409	0.590	0.000
L43.0 Hypertrophic lichen planus	0.409	0.590	0.000
L43.8 Other lichen planus	0.402	0.598	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.001	0.611	0.389
C44.5 Skin of trunk	0.386	0.614	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.377	0.623	0.000
E06 Thyroiditis	0.000	0.627	0.372
C44.6 Skin of upper limb, including shoulder	0.369	0.631	0.000
I21.4 Acute subendocardial myocardial infarction	0.346	0.654	0.000
C44.4 Skin of scalp and neck	0.343	0.657	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.340	0.660	0.000
C44.8 Overlapping lesion of skin	0.337	0.662	0.000
L41.9 Parapsoriasis, unspecified	0.328	0.671	0.000
L41.8 Other parapsoriasis	0.328	0.671	0.000
L41.5 Retiform parapsoriasis	0.328	0.671	0.000
L41.4 Large plaque parapsoriasis	0.328	0.671	0.000
L41.3 Small plaque parapsoriasis	0.328	0.671	0.000
L41.2 Lymphomatoid papulosis	0.328	0.671	0.000
L41.1 Pityriasis lichenoides chronica	0.328	0.671	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.328	0.671	0.000
L44.9 Papulosquamous disorder, unspecified	0.328	0.671	0.000
L44.8 Other specified papulosquamous disorders	0.328	0.671	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.328	0.671	0.000
L44.3 Lichen ruber moniliformis	0.328	0.671	0.000
L44.2 Lichen striatus	0.328	0.671	0.000
L44.1 Lichen nitidus	0.328	0.671	0.000
L44.0 Pityriasis rubra pilaris	0.328	0.671	0.000
M07.6 Other enteropathic arthropathies	0.313	0.687	0.000
M07.5 Arthropathy in ulcerative colitis	0.313	0.687	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.313	0.687	0.000
M07.2 Psoriatic spondylitis	0.313	0.687	0.000
M07.1 Arthritis mutilans	0.313	0.687	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.313	0.687	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.273	0.727	0.000
E06.5 Other chronic thyroiditis	0.000	0.731	0.268
E06.4 Drug-induced thyroiditis	0.000	0.733	0.267
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.733	0.267
E06.1 Subacute thyroiditis	0.000	0.733	0.267
E06.0 Acute thyroiditis	0.000	0.733	0.267
C44.1 Skin of eyelid, including canthus	0.258	0.742	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.228	0.772	0.000
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.224	0.775	0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.224	0.775	0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.224	0.775	0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.224	0.775	0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.224	0.775	0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.224	0.775	0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.224	0.775	0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.224	0.775	0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.224	0.775	0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.224	0.775	0.000
M07.19 Arthritis mutilans (Site unspecified)	0.224	0.775	0.000
M07.18 Arthritis mutilans (Other)	0.224	0.775	0.000
M07.17 Arthritis mutilans (Ankle and foot)	0.224	0.775	0.000
M07.16 Arthritis mutilans (Lower leg)	0.224	0.775	0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.224	0.775	0.000
M07.14 Arthritis mutilans (Hand)	0.224	0.775	0.000
M07.13 Arthritis mutilans (Forearm)	0.224	0.775	0.000
M07.12 Arthritis mutilans (Upper arm)	0.224	0.775	0.000
M07.11 Arthritis mutilans (Shoulder region)	0.224	0.775	0.000
M07.10 Arthritis mutilans (Multiple sites)	0.224	0.775	0.000
M07.29 Psoriatic spondylitis (Site unspecified)	0.224	0.775	0.000
M07.28 Psoriatic spondylitis (Other)	0.224	0.775	0.000
M07.27 Psoriatic spondylitis (Ankle and foot)	0.224	0.775	0.000
M07.26 Psoriatic spondylitis (Lower leg)	0.224	0.775	0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.224	0.775	0.000
M07.24 Psoriatic spondylitis (Hand)	0.224	0.775	0.000
M07.23 Psoriatic spondylitis (Forearm)	0.224	0.775	0.000
M07.22 Psoriatic spondylitis (Upper arm)	0.224	0.775	0.000
M07.21 Psoriatic spondylitis (Shoulder region)	0.224	0.775	0.000
M07.20 Psoriatic spondylitis (Multiple sites)	0.224	0.775	0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.224	0.775	0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.224	0.775	0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.224	0.775	0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.224	0.775	0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.224	0.775	0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.224	0.775	0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.224	0.775	0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.224	0.775	0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.224	0.775	0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)	0.224	0.775	0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)	0.224	0.775	0.000
M07.58 Arthropathy in ulcerative colitis (Other)	0.224	0.775	0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)	0.224	0.775	0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)	0.224	0.775	0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)	0.224	0.775	0.000
M07.54 Arthropathy in ulcerative colitis (Hand)	0.224	0.775	0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)	0.224	0.775	0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)	0.224	0.775	0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)	0.224	0.775	0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)	0.224	0.775	0.000
M07.69 Other enteropathic arthropathies (Site unspecified)	0.224	0.775	0.000
M07.68 Other enteropathic arthropathies (Other)	0.224	0.775	0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)	0.224	0.775	0.000
M07.66 Other enteropathic arthropathies (Lower leg)	0.224	0.775	0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)	0.224	0.775	0.000
M07.64 Other enteropathic arthropathies (Hand)	0.224	0.775	0.000
M07.63 Other enteropathic arthropathies (Forearm)	0.224	0.775	0.000
M07.62 Other enteropathic arthropathies (Upper arm)	0.224	0.775	0.000
M07.61 Other enteropathic arthropathies (Shoulder region)	0.224	0.775	0.000
M07.60 Other enteropathic arthropathies (Multiple sites)	0.224	0.775	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.222	0.778	0.000
T43.2 Other and unspecified antidepressants	0.220	0.780	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.219	0.781	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.215	0.785	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.212	0.788	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.211	0.789	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.208	0.792	0.000
T42.4 Benzodiazepines	0.197	0.803	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.184	0.816	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.182	0.818	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.182	0.818	0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.181	0.819	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.180	0.820	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.820	0.180
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.174	0.825	0.000
E06.9 Thyroiditis, unspecified	0.001	0.831	0.168
E10 Insulin-dependent diabetes mellitus	0.000	0.832	0.168
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.167	0.833	0.000
E10-E14 Diabetes mellitus	0.000	0.834	0.166
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.166	0.834	0.000
T43.9 Psychotropic drug, unspecified	0.164	0.836	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.164	0.836	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.162	0.838	0.000
E10.9 Without complications	0.000	0.839	0.161
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.161	0.839	0.000
T36 Poisoning by systemic antibiotics	0.159	0.841	0.000
T50.4 Drugs affecting uric acid metabolism	0.159	0.841	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.159	0.841	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.157	0.843	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.157	0.843	0.000
T50.7 Analeptics and opioid receptor antagonists	0.152	0.847	0.000
T50.5 Appetite depressants	0.152	0.847	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.152	0.847	0.000
T50.1 Loop [high-ceiling] diuretics	0.152	0.847	0.000
T50.0 Mineralocorticoids and their antagonists	0.152	0.847	0.000
T42.1 Iminostilbenes	0.152	0.848	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.152	0.848	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.151	0.849	0.000
T42.3 Barbiturates	0.151	0.849	0.000
T42.2 Succinimides and oxazolidinediones	0.151	0.849	0.000
E40-E46 Malnutrition	0.000	0.849	0.151
T43.6 Psychostimulants with abuse potential	0.150	0.850	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.150	0.850	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.148	0.851	0.000
T42.0 Hydantoin derivatives	0.147	0.853	0.000
E10.1 With ketoacidosis	0.000	0.853	0.147
T50.6 Antidotes and chelating agents, not elsewhere classified	0.147	0.853	0.000
E06.3 Autoimmune thyroiditis	0.000	0.854	0.146
T50.8 Diagnostic agents	0.146	0.854	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.855	0.145
T37.8 Other specified systemic anti-infectives and antiparasitics	0.143	0.857	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.141	0.859	0.000
E10.8 With unspecified complications	0.000	0.859	0.141
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.141	0.859	0.000
T47.0 Histamine H(2)-receptor antagonists	0.141	0.859	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.141	0.859	0.000
E10.0 With coma	0.000	0.861	0.139
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.139	0.861	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.137	0.863	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.137	0.863	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.135	0.865	0.000
T38.1 Thyroid hormones and substitutes	0.134	0.866	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.132	0.868	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.132	0.868	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.132	0.868	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.132	0.868	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.132	0.868	0.000
T44.0 Anticholinesterase agents	0.132	0.868	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.869	0.131
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.131	0.869	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.131	0.869	0.000
T47.7 Emetics	0.131	0.869	0.000
T47.6 Antidiarrhoeal drugs	0.131	0.869	0.000
T47.5 Digestants	0.131	0.869	0.000
T47.4 Other laxatives	0.131	0.869	0.000
T47.3 Saline and osmotic laxatives	0.131	0.869	0.000
T47.2 Stimulant laxatives	0.131	0.869	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.129	0.871	0.000
T48.5 Anti-common-cold drugs	0.129	0.871	0.000
T48.4 Expectorants	0.129	0.871	0.000
T48.3 Antitussives	0.129	0.871	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.129	0.871	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.129	0.871	0.000
T48.0 Oxytocic drugs	0.129	0.871	0.000
E10.6 With other specified complications	0.000	0.872	0.128
T36.3 Macrolides	0.126	0.874	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.000	0.874	0.126
E14 Unspecified diabetes mellitus	0.000	0.874	0.126
E10.4 With neurological complications	0.000	0.874	0.126
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.125	0.875	0.000
T37.5 Antiviral drugs	0.125	0.875	0.000
T37.4 Anthelminthics	0.125	0.875	0.000
T37.3 Other antiprotozoal drugs	0.125	0.875	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.125	0.875	0.000
T37.1 Antimycobacterial drugs	0.125	0.875	0.000
T37.0 Sulphonamides	0.125	0.875	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.123	0.877	0.000
E10.2 With renal complications	0.000	0.880	0.120
E10.7 With multiple complications	0.000	0.880	0.120
E16 Other disorders of pancreatic internal secretion	0.000	0.880	0.120
G04 Encephalitis, myelitis and encephalomyelitis	0.000	0.880	0.120
E10.3 With ophthalmic complications	0.000	0.880	0.120
C43-C44 Melanoma and other malignant neoplasms of skin	0.119	0.881	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.881	0.119
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.000	0.884	0.116
T38.9 Other and unspecified hormone antagonists	0.116	0.884	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.116	0.884	0.000
T38.7 Androgens and anabolic congeners	0.116	0.884	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.116	0.884	0.000
T38.5 Other oestrogens and progestogens	0.116	0.884	0.000
T38.4 Oral contraceptives	0.116	0.884	0.000
T38.2 Antithyroid drugs	0.116	0.884	0.000
T38.0 Glucocorticoids and synthetic analogues	0.116	0.884	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.116	0.884	0.000
T36.9 Systemic antibiotic, unspecified	0.114	0.886	0.000
T36.8 Other systemic antibiotics	0.114	0.886	0.000
T36.7 Antifungal antibiotics, systemically used	0.114	0.886	0.000
T36.6 Rifamycins	0.114	0.886	0.000
T36.5 Aminoglycosides	0.114	0.886	0.000
T36.4 Tetracyclines	0.114	0.886	0.000
T36.2 Chloramphenicol group	0.114	0.886	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.114	0.886	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.114	0.886	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.114	0.886	0.000
T46.7 Peripheral vasodilators	0.114	0.886	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.114	0.886	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.000	0.886	0.114
T41.5 Therapeutic gases	0.113	0.887	0.000
T41.4 Anaesthetic, unspecified	0.113	0.887	0.000
T41.3 Local anaesthetics	0.113	0.887	0.000
T41.2 Other and unspecified general anaesthetics	0.113	0.887	0.000
T41.1 Intravenous anaesthetics	0.113	0.887	0.000
T41.0 Inhaled anaesthetics	0.113	0.887	0.000
T49.9 Topical agent, unspecified	0.113	0.887	0.000
T49.8 Other topical agents	0.113	0.887	0.000
T49.7 Dental drugs, topically applied	0.113	0.887	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.113	0.887	0.000
T49.5 Ophthalmological drugs and preparations	0.113	0.887	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.113	0.887	0.000
T49.3 Emollients, demulcents and protectants	0.113	0.887	0.000
T49.2 Local astringents and local detergents	0.113	0.887	0.000
T49.1 Antipruritics	0.113	0.887	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.113	0.887	0.000
G00 Bacterial meningitis, not elsewhere classified	0.000	0.888	0.112
I20.8 Other forms of angina pectoris	0.111	0.889	0.000
G03 Meningitis due to other and unspecified causes	0.000	0.889	0.111
E65-E68 Obesity and other hyperalimentation	0.000	0.889	0.111
T46.4 Angiotensin-converting-enzyme inhibitors	0.111	0.889	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.000	0.890	0.110
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.891	0.109
E45 Retarded development following protein-energy malnutrition	0.000	0.891	0.109
E43 Unspecified severe protein-energy malnutrition	0.000	0.891	0.109
E42 Marasmic kwashiorkor	0.000	0.891	0.109
E41 Nutritional marasmus	0.000	0.891	0.109
E40 Kwashiorkor	0.000	0.891	0.109
G09 Sequelae of inflammatory diseases of central nervous system	0.000	0.892	0.108
E15 Nondiabetic hypoglycaemic coma	0.000	0.896	0.104
T46.3 Coronary vasodilators, not elsewhere classified	0.102	0.898	0.000
G00.1 Pneumococcal meningitis	0.000	0.898	0.102
G06 Intracranial and intraspinal abscess and granuloma	0.000	0.898	0.101
E14.8 With unspecified complications	0.000	0.899	0.101
G03.9 Meningitis, unspecified	0.000	0.899	0.101
T36.0 Penicillins	0.100	0.900	0.000
E14.2 Withrenal complications	0.000	0.900	0.100
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.000	0.901	0.099
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.000	0.902	0.098
F41 Other anxiety disorders	0.097	0.903	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.000	0.903	0.097
E16.2 Hypoglycaemia, unspecified	0.000	0.903	0.097
T46.5 Other antihypertensive drugs, not elsewhere classified	0.096	0.904	0.000
E16.1 Other hypoglycaemia	0.000	0.904	0.096
T46.1 Calcium-channel blockers	0.095	0.904	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.000	0.905	0.095
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.095	0.905	0.000
E14.9 Without complications	0.000	0.907	0.093
E14.3 With ophthalmic complications	0.000	0.907	0.093
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.000	0.909	0.091
E14.5 With peripheral circulatory complications	0.000	0.909	0.090
E14.7 With multiple complications	0.000	0.910	0.090
E14.0 With coma	0.000	0.910	0.090
G00.9 Bacterial meningitis, unspecified	0.000	0.910	0.090
E14.1 With ketoacidosis	0.000	0.911	0.089
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.913	0.086
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.913	0.086
E16.4 Abnormal secretion of gastrin	0.000	0.913	0.086
E16.3 Increased secretion of glucagon	0.000	0.913	0.086
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.000	0.914	0.086
G04.1 Tropical spastic paraplegia	0.000	0.914	0.086
G04.0 Acute disseminated encephalitis	0.000	0.914	0.086
E13 Other specified diabetes mellitus	0.000	0.914	0.086
E12.9 Without complications	0.000	0.914	0.086
E12.8 With unspecified complications	0.000	0.914	0.086
E12.7 With multiple complications	0.000	0.914	0.086
E12.6 With other specified complications	0.000	0.914	0.086
E12.5 With peripheral circulatory complications	0.000	0.914	0.086
E12.4 With neurological complications	0.000	0.914	0.086
E12.3 With ophthalmic complications	0.000	0.914	0.086
E12.2 With renal complications	0.000	0.914	0.086
E12.1 With ketoacidosis	0.000	0.914	0.086
E12.0 With coma	0.000	0.914	0.086
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.915	0.085
T45.9 Primarily systemic and haematological agent, unspecified	0.083	0.917	0.000
T45.8 Other primarily systemic and haematological agents	0.083	0.917	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.083	0.917	0.000
T45.6 Fibrinolysis-affecting drugs	0.083	0.917	0.000
T45.4 Iron and its compounds	0.083	0.917	0.000
T45.3 Enzymes, not elsewhere classified	0.083	0.917	0.000
G06.1 Intraspinal abscess and granuloma	0.000	0.917	0.083
E10.5 With peripheral circulatory complications	0.000	0.917	0.083
T45.0 Antiallergic and antiemetic drugs	0.082	0.918	0.000
G06.2 Extradural and subdural abscess, unspecified	0.000	0.918	0.082
T43.0 Tricyclic and tetracyclic antidepressants	0.081	0.919	0.000
E50-E64 Other nutritional deficiencies	0.000	0.919	0.081
F41.3 Other mixed anxiety disorders	0.081	0.919	0.000
E14.6 With other specified complications	0.000	0.919	0.081
G00.3 Staphylococcal meningitis	0.000	0.919	0.081
G00.2 Streptococcal meningitis	0.000	0.919	0.081
G00.0 Haemophilus meningitis	0.000	0.919	0.081
F41.1 Generalised anxiety disorder	0.080	0.919	0.000
G03.8 Meningitis due to other specified causes	0.000	0.920	0.080
G03.2 Benign recurrent meningitis [Mollaret]	0.000	0.920	0.080
G03.1 Chronic meningitis	0.000	0.920	0.080
G03.0 Nonpyogenic meningitis	0.000	0.920	0.080
G02.0 Meningitis in viral diseases classified elsewhere	0.000	0.920	0.080
E67 Other hyperalimentation	0.000	0.920	0.080
E68 Sequelae of hyperalimentation	0.000	0.920	0.080
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.000	0.921	0.079
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.000	0.921	0.079
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.000	0.921	0.079
T45.5 Anticoagulants	0.078	0.922	0.000
E44.1 Mild protein-energy malnutrition	0.000	0.922	0.078
E44.0 Moderate protein-energy malnutrition	0.000	0.922	0.078
E66 Obesity	0.000	0.923	0.077
F41.8 Other specified anxiety disorders	0.075	0.925	0.000
E14.4 With neurological complications	0.000	0.925	0.075
T45.1 Antineoplastic and immunosuppressive drugs	0.075	0.925	0.000
E66.8 Other obesity	0.000	0.927	0.073
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.000	0.929	0.071
G02.1 Meningitis in mycoses	0.000	0.929	0.071
F40-F48 Neurotic, stress-related and somatoform disorders	0.071	0.929	0.000
G00.8 Other bacterial meningitis	0.000	0.932	0.068
T45.2 Vitamins, not elsewhere classified	0.067	0.932	0.000
E65 Localised adiposity	0.000	0.935	0.065
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.063	0.937	0.000
E04 Other non-toxic goitre	0.001	0.938	0.061
E13.8 With unspecified complications	0.000	0.938	0.062
E13.7 With multiple complications	0.000	0.938	0.062
E13.6 With other specified complications	0.000	0.938	0.062
E13.5 With peripheral circulatory complications	0.000	0.938	0.062
E13.4 With neurological complications	0.000	0.938	0.062
E13.2 With renal complications	0.000	0.938	0.062
E13.1 With ketoacidosis	0.000	0.938	0.062
E13.0 With coma	0.000	0.938	0.062
M05-M14 Inflammatory polyarthropathies	0.062	0.938	0.000
G06.0 Intracranial abscess and granuloma	0.000	0.939	0.061
F60 Specific personality disorders	0.060	0.940	0.000
F43 Reaction to severe stress, and adjustment disorders	0.060	0.940	0.000
W19.9 Unspecified place	0.000	0.941	0.059
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.941	0.058
E63 Other nutritional deficiencies	0.000	0.941	0.058
E56 Other vitamin deficiencies	0.000	0.941	0.058
E50 Vitamin A deficiency	0.000	0.941	0.058
E60 Dietary zinc deficiency	0.000	0.941	0.058
E59 Dietary selenium deficiency	0.000	0.941	0.058
E54 Ascorbic acid deficiency	0.000	0.941	0.058
E52 Niacin deficiency [pellagra]	0.000	0.941	0.058
F60.9 Personality disorder, unspecified	0.058	0.942	0.000
E51 Thiamine deficiency	0.000	0.942	0.058
F48 Other neurotic disorders	0.058	0.942	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations